These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 79045)

  • 21. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.
    Ninane G; Joly J; Kraytman M
    Br Med J; 1978 Feb; 1(6108):276-8. PubMed ID: 620304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid.
    Fiocchi A; Zuccotti G; Bellù R; Marangione P; Riva E; Giovannini M
    J Int Med Res; 1990; 18(4):326-33. PubMed ID: 2227080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Refractory respiratory tract infections. 9. Chemotherapy of recent respiratory tract infections. a. Branhamella catarrhalis infection].
    Nagatake T; Rikitomi N; Tao M; Watanabe K; Mbaki N; Matsumoto K
    Nihon Rinsho; 1987 Mar; 45(3):604-10. PubMed ID: 3599486
    [No Abstract]   [Full Text] [Related]  

  • 25. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clavulanic acid and respiratory infection.
    Roberts DE; Cole P
    J Antimicrob Chemother; 1981 Jan; 7(1):112. PubMed ID: 6970741
    [No Abstract]   [Full Text] [Related]  

  • 29. Branhamella catarrhalis--an emerging human pathogen.
    Doern GV
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):191-201. PubMed ID: 3514103
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.
    Slevin NJ; Aitken J; Thornley PE
    Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Branhamella catarrhalis respiratory tract infections].
    Letonja S; Music E; Kumelj M
    Plucne Bolesti; 1990; 42(3-4):144-7. PubMed ID: 2129309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.
    Mehtar S
    Scott Med J; 1982; 27 Spec No.():S24-7. PubMed ID: 6984777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):353-60. PubMed ID: 15954852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of gonorrhoea due to penicillinase producing Neisseria gonorrhoeae in Japan 1981-3 and treatment using a new antibiotic combination, BRL25000 (amoxycillin and clavulanic acid).
    Osato K; Tsugami H; Harada K; Maruyama J
    Genitourin Med; 1986 Jun; 62(3):158-62. PubMed ID: 3089905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 39. [Isolation of Branhamella catarrhalis from sputum and clinical features of bronchopulmonary infection due to Branhamella catarrhalis].
    Kinoshita A; Mukae H; Takase T; Ishino T; Kohno S; Kanda T; Yamaguchi K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):875-81. PubMed ID: 2120499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.